Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers - Oncogene
- ️Phang, J M
- ️Mon Sep 15 2008
Albini A, Sporn MB . (2007). The tumor microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139–147.
Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M et al. (2003). Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Cancer Res 63: 728–734.
Bensaad K, Vousden KH . (2007). p53: new roles in metabolism. Trends Cell Biol 17: 286–291.
Buchanan FG, Wang D, Bargiacchi F, DuBois RN . (2003). Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J Biol Chem 278: 35451–35457.
Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS . (2005). Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science 310: 1504–1510.
Chen JJ, Huang WC, Chen CC . (2005). Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein. Mol Biol Cell 16: 5579–5591.
Dannenberg AJ, Lippman SM, Mann JR, Subbaramaiah K, DuBois RN . (2005). Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J Clin Oncol 23: 254–266.
Dixon DA . (2004). Dysregulated post-transcriptional control of COX-2 gene expression in cancer. Curr Pharm Des 10: 635–646.
Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM . (2000). Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 275: 11750–11757.
Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D et al. (2001). Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 61: 1810–1815.
Gupta RA, Dubois RN . (2001). Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1: 11–21.
Hagedorn CH, Phang JM . (1986). Catalytic transfer of hydride ions from NADPH to oxygen by the interconversions of proline and delta 1-pyrroline-5-carboxylate. Arch Biochem Biophys 248: 166–174.
Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W . (2002). Loss of heterozygosity on chromosome 22 in human ependymomas. Acta Neuropathol (Berl) 103: 415–420.
Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A et al. (2005). Cancer statistics, 2005. CA Cancer J Clin 55: 10–30.
Kawamori T, Rao CV, Seibert K, Reddy BS . (1998). Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58: 409–412.
Kim J, Adam RM, Freeman MR . (2005). Trafficking of nuclear heparin-binding epidermal growth factor-like growth factor into an epidermal growth factor receptor-dependent autocrine loop in response to oxidative stress. Cancer Res 65: 8242–8249.
Kinzler KW, Vogelstein B . (1996). Lessons from hereditary colorectal cancer. Cell 87: 159–170.
Korswagen HC . (2006). Regulation of the Wnt/beta-catenin pathway by redox signaling. Dev Cell 10: 687–688.
Liu X, Lazenby AJ, Siegal GP . (2006a). Signal transduction cross talk during colorectal tumorigenesis. Adv Anat Pathol 13: 270–274.
Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ et al. (2005). MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 26: 1335–1342.
Liu Y, Borchert GL, Phang JM . (2004). Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. J Biol Chem 279: 18694–18700.
Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM . (2006b). Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25: 5640–5647.
Maxwell SA, Rivera A . (2003). Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J Biol Chem 278: 9784–9789.
McDonald-McGinn DM, Reilly A, Wallgren-Pettersson C, Hoyme HE, Yang SP, Adam MP et al. (2006). Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Am J Med Genet A 140: 906–909.
Merida I, Avila-Flores A . (2006). Tumor metabolism: new opportunities for cancer therapy. Clin Transl Oncol 8: 711–716.
Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E et al. (1996). Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803–809.
Pandhare J, Cooper SK, Phang JM . (2006). Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem 281: 2044–2052.
Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B . (1997). A model for p53-induced apoptosis. Nature 389: 300–305.
Prescott SM, Fitzpatrick FA . (2000). Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta 1470: M69–M78.
Rivera A, Maxwell SA . (2005). The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 280: 29346–29354.
Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D et al. (1999). Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8: 2359–2368.
Shao J, Evers BM, Sheng H . (2004). Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells. J Biol Chem 279: 14287–14293.
Shao J, Jung C, Liu C, Sheng H . (2005). Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. J Biol Chem 280: 26565–26572.
Surazynski A, Donald S, Cooper S, Whiteside M, Salnikow K, Liu Y et al. (2008). Extracellular Matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122: 1435–1440.
Williams CS, Smalley W, DuBois RN . (1997). Aspirin use and potential mechanisms for colorectal cancer prevention. J Clin Invest 100: 1325–1329.
Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318: 1108–1113.
Worthley DL, Whitehall VL, Spring KJ, Leggett BA . (2007). Colorectal carcinogenesis: road maps to cancer. World J Gastroenterol 13: 3784–3791.
Yeh GC, Phang JM . (1988). Stimulation of phosphoribosyl pyrophosphate and purine nucleotide production by pyrroline 5-carboxylate in human erythrocytes. J Biol Chem 263: 13083–13089.